Review: DIRECT - China Life Whole Life Plan

The DIRECT - China Life Whole Life Plan is a commission-free Direct Purchase Insurance (DPI) product offered by China Life Insurance (Singapore) Pte. Ltd. As a participating whole life plan, it provides lifelong coverage for death and terminal illness, along with total and permanent disability (TPD) cover up to age 65. The plan allows policyholders to choose between two premium payment terms: paying until age 69 or age 84. Being a "no-frills" direct plan, it is sold without financial adviser involvement, offering standardized coverage with level premiums guaranteed throughout the payment term. It includes non-guaranteed bonuses linked to the performance of China Life’s Participating Fund, which has an A3 credit rating from Moody’s.

How it compares

When evaluated against similar DPI whole life plans for a 35-year-old male non-smoker with a $100,000 sum assured and premiums payable until age 85, the China Life plan presents a distinct cost-benefit profile.

Premium Costs: The China Life plan has an annual premium of $2,219. This is notably higher than its peers:

• It is 36% more expensive than the DIRECT - HSBC Life Protector II ($1,628/yr).
• It is 49% more expensive than the DIRECT - Singlife Whole Life ($1,492/yr).
• It is 19% more expensive than the DIRECT- ManuAssure Life 85 ($1,863/yr).

Surrender Value (Year 20): Despite the higher premium input, the cash value accumulation shows mixed results. At year 20, the China Life plan provides a surrender value of $17,630.

• This is significantly lower than HSBC Life’s $20,863.
• It is substantially higher than Singlife’s $3,812.
• It is higher than ManuAssure’s $12,600.

Returns and Expenses: The plan reports a 5-year net return of 2.36% with a total expense ratio (TER) of 3.31% over 5 years. In comparison:

• HSBC Life offers a lower TER (1.88%) but also a lower 5-year net return (1.16%).
• Singlife offers a higher 5-year net return (1.24% is lower than China's, but its 10-year return is 4.07%, which is not directly comparable to China Life’s missing 10-year data in this specific table row, though the product summary notes a 3/5yr par-fund return of 5.28%/2.36%).
• ManuAssure has a lower TER (2.40%) but no 5-year net return data provided.

Pros

• Established Insurer: Backed by China Life Insurance (Singapore) with an A3 credit rating from Moody’s, offering stability for long-term policies.
• Guaranteed Level Premiums: Premiums remain fixed throughout the chosen payment term (up to age 69 or 84), aiding in budgeting.
• Participating Benefits: Includes non-guaranteed reversionary and terminal bonuses, allowing policyholders to benefit from the Participating Fund’s performance.
• Terminal Illness Benefit: Covers terminal illness by advancing the death benefit, providing financial support if diagnosed with an illness expected to result in death within 12 months.

Cons

• Higher Premiums: The annual premium is the highest among the compared peers for the same coverage basis.
• Moderate Cash Value: While better than Singlife, the year-20 surrender value ($17,630) is lower than HSBC Life’s ($20,863).
• Limited Payment Flexibility: Does not allow SRS or CPFIS premium payments, restricting funding sources to cash.
• No Underwriting Waiver: Requires standard medical underwriting, unlike some competitors that may offer simplified issue options.

Who it may suit

This plan may suit consumers who prioritize the financial strength of a large, established insurer (China Life) over the lowest possible premium costs. It is appropriate for those comfortable with a direct purchase model and who wish to participate in potential fund bonuses through non-guaranteed benefits. However, cost-sensitive buyers seeking the lowest premiums should consider HSBC Life or Singlife, while those prioritizing maximum cash value accumulation at year 20 might find HSBC Life more efficient despite lower initial returns.

This is general information based on CompareFIRST.sg data, not financial advice. Premiums and features can change; please verify with the insurer or a MAS-licensed financial adviser before making any decision.